Journal Article

DKFZ-2025-01769

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Radiomics-based prediction of HCC response to atezolizumab/bevacizumab

Rodriguez, I. ; Vellala, A. ; Itzel, T. ; Daza, J. ; Vácha, M. ; Chang, D.-H. ; Debic, M. ; Dill, M.DKFZ* ; Seidensticker, M. ; Mayerle, J. ; Munker, S. ; Schoenberg, S. ; Müller, L. ; Galle, P. ; Weinmann, A. ; Tamandl, D. ; Pinter, M. ; Scheiner, B. ; Weiss, C. ; Pech, M. ; Sinner, F. ; Keitel, V. ; Venerito, M. ; Ebert, M. ; Teufel, A. ; Froelich, M.

2025
Spandidos Publ. Athens

Please use a persistent id in citations: doi:10.3892/ol.2025.15229

---

Contributing Institute(s):

1. NWG Experimentelle Hepatologie, Entzündung und Krebs (D500)

Research Program(s):

1. 314 - Immunologie und Krebs (POF4-314) (POF4-314)

Appears in the scientific report 2025

---

Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Ebsco Academic Search ; Essential Science Indicators ; IF < 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---